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It has become increasingly clear that microRNAs play an important role in many human diseases
including cancer. Here, we show that expression of miR-21 in HEK293 and several colorectal cancer
cells was found inversely correlated with ras homolog gene family, member B (RhoB) expression.
miR-21 expression signiﬁcantly suppressed RhoB 30 UTR luciferase-reporter activity, but the inhibi-
tory effect was lost when the putative target sites were mutated. Exogenous miR-21 over-expression
mimicked the effect of RhoB knockdown in promoting proliferation and invasion and inhibiting
apoptosis,whereas anti-miR-21 or RhoB expression yielded opposite effects, in colorectal cancer cells.
These results suggest that miR-21 is a regulator of RhoB expression and RhoB could be a useful target
in exploring the potential therapeutic beneﬁts ofmiR-21mediated tumor cell behaviors in colorectal
cancer.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The RhoA, ras homolog gene family, member B (RhoB), and
RhoC proteins form a closely related subgroup of the Rho GTPase
family that play crucial roles in the regulation of actin cytoskele-
ton, cell survival and gene expression [1–3]. Although they share
more than 85% sequence identity, RhoA, RhoB and RhoC have dif-
ferent cellular functions and appear to show distinct, sometimes
opposite, function in carcinogenesis. RhoA regulates cell contractil-
ity and proliferation via the actomyosin machinery and multiple
growth related gene expression pathways, RhoC is required for
cell–cell adhesion and cell invasion, whereas RhoB, which has a
unique endosome localization pattern, is involved in membrane
trafﬁcking and cell survival. Whereas RhoA and RhoC are often
found over-expressed in tumors, RhoB expression is down-regu-
lated in multiple type of cancers [4–7]. Additionally, in contrast
to other Rho family members, RhoB protein is relatively short-lived
in cells and its protein expression is readily inducible upon expo-
sure to a wide-variety of biological stimuli including growth fac-
tors such as platelet-derived growth factor (PDGF), epidermal
growth factor (EGF) and transforming growth factor-b (TGF-b)chemical Societies. Published by E
olog gene family, member B;[8–10]. The induction of RhoB by stress suggests that RhoB is
involved in cell growth control and/or DNA damage repair mecha-
nisms, consistent with the ﬁnding that overexpression of RhoB,
whether in its geranylgeranylated form (RhoB-GG) or farnesylated
form (RhoB-F), can inhibit tumor cell growth and transformation
[11]. RhoB was shown to be down-regulated in head and neck
carcinoma and lung cancer but over-expressed in breast cancer
[12–14]. Our previous report has shown that, in gastric cancer tis-
sue and cell lines, RhoB expression is signiﬁcantly suppressed, and
is regulated by histone deacetylation, not by DNA methylation, at
the epigenetic level [15,16].
MicroRNAs (miRNAs) are approximately 22-nucleotide,
non-coding RNAs that can regulate the expression of multiple
genes by targeting mRNAs posttranscriptionally. miRNAs, in con-
juction with Argonaute (Ago) protein, function to posttranscrip-
tionally silence genes through either suppressing translation or
degrading miR-bound mRNA by complementing the 3 untranslated
region (30 UTR) of the cognate mRNAs [17–19]. It is estimated that
as high as 30% of protein-coding genes could serve as miRNA
targets. Due to the fact that miRNAs often regulate multiple tran-
scripts, they are involved in diverse biological processes including
cell differentiation, proliferation, apoptosis, metabolism, protein
secretion, and viral infection. Recently, several studies have
described ﬁndings of aberrant expression of miRNAs in human
tumors and have investigated their potential role as oncogenes or
tumor suppressor genes, depending on the targets they regulatelsevier B.V. All rights reserved.
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most highly expressed miRNA in various tumors, including colo-
rectal [23], GBM [24], breast, lung, prostate, pancreas, and stomach
cancers [25,26]. Increased miR-21 expression in these tumors is
associated with cell proliferation, migration, invasion and metasta-
sis [27], suggesting that miR-21 is a key regulatory molecule in
cancer initiation and/or progression.
Our previous studies have shown that among Rho GTPases, RhoA
and Cdc42 can be directly regulated by miR-137 and miR-185 that
suppress the growth and invasion activities of colorectal cancer cells
[28,29]. To date a role for RhoB and its relationship with miRNAs in
colorectal cancer has not been reported. The current study is aimed
at elucidating the regulatorymechanismof RhoBbymiRNAs in colo-
rectal cancer. Our data show that miR-21 can negatively regulate
RhoB expression in colorectal cancer cells. Additionally, loss and
ectopic RhoB expression induced by miR-21 or RhoB knockdown,
and by anti-miR-21 or RhoB expression, respectively, gives opposite
effects in several cell phenotypes, including proliferation, invasion
and apoptosis, linking miRNA21-RhoB regulatory pathway to colo-
rectal cancer cell functions.
2. Materials and methods
2.1. Cell culture
All cell lines weremaintained in RPMI 1640medium (Invitrogen,
Gaithersburg, MD, USA) supplemented with 10% heat-inactivated
fetal bovine serum (FBS) (Gibco, Gaithersburg, USA), 100 units/ml
of penicillin G sodium, and 100 lg/ml streptomycin sulfate (Sigma,
Saint Louis,MO, USA) in a humidiﬁed atmosphere containing 5%CO2
at 37 C.
2.2. Transfection
Control oligo, hsa-miR-21, control anti-miR, anti-miR-21 and
siRNA targeting RhoB coding sequences (si-RhoB, 50-CCGTCTTCGA-
GAACTATGT dTdT-30, 30-dTdT GGCAGAAGCTCTTGATACA-50) were
chemically synthesized by RiboBio (RiboBio, Guangzhou, China).
RNA oligonucleotides were transfected into cells using Lipofect-
amine 2000 (Invitrogen) according to the manufacturer’s protocol.
2.3. Plasmid construct
The 30 UTR of the human RhoB gene (NM_004040) was PCR
ampliﬁed from human genomic DNA using primers 50-GCTCT-
AGATCCCGCCCAAGCATGAAC-30 and 50-GCTCTAGACCATTTTATAAA
TGTCATCATC-30, and cloned into the Xba1-site of pGL3-control
vector (Promega, Madison, WI, USA), which is designated pGL3-
RhoB-wt after sequencing. Site-directed mutagenesis of the miR-
21 target-site in the RhoB 30 UTRwas carried out using site-directed
mutagenesis kit (TaKaRa, Dalian, China), with pGL3-RhoB-wt as a
template, and named pGL3-RhoB-mut (primers: FW, 50-TTCTCGC
GATGATGTATACAGTTTTTTATG-30, RV, 50-CTTTTATGTAAACATCA-
TAAGCTCA-30). The pcEFL-GST-RhoB and pcEFL-GST vectors were
kindly provided by Professor Zheng (Cincinnati Children’s Hospital,
Ohio).
2.4. Luciferase assay
Cells were seeded in 24-well plates 1 d before transfection. For
reporter assays, the cells were transiently cotransfected in 24-well
plates with 0.3 lg wt or mutant reporter plasmid and 60 nM
control miRNA or miR-21 using lipofectamine 2000 (Invitrogen).
Fireﬂy and Renilla luciferase activities were measured consecu-
tively by using Dual Luciferase Assay (Promega) according to themanufacturer’s instructions, and normalized for transfection efﬁ-
ciency by the control vector containing Renilla luciferase, pRL-TK
(promega). Three independent experiments were performed in
triplicate.
2.5. Cell growth assay
SW1116 and Colo320 colorectal cancer cells were seeded in
96-well plates 1 d before transfection. After transfecting with
miR-21, si-RhoB, control oligo, anti-miR-21, control anti-miR,
pcEFL-GST-RhoB or pcEFL-GST, the Cell Counting Kit-8 (Dojindo,
Kumamoto, Japan) was used to determine relative cell growth.
2.6. In vitro apoptosis assay
Forty-eight hours after transfection, cells were incubated in
100 ll binding buffer containing 0.2 lg Annexin V conjugate ﬂuo-
rescein isothiocyanate and then stained with propidium iodide fol-
lowed by FACS analysis (Fluorescence Activated Cell Sorter Scan)
(Becton Dickinson, Mountain View, CA, USA).
2.7. Matrigel invasion assay
Twenty-four hours after transfection, 2  104 cells (SW1116
cell) or 4  104 cells (Colo320 cell) were suspended in 0.25 ml of
culture medium with 1% FBS and plated in the top chamber with
matrigel-coated membrane (24-well insert; pore size, 8 mm;
Becton Dickinson). The cells were incubated for 36 h, after which
the cells that did not invade through the pores were removed by
a cotton swab. Cells on the lower surface of the membrane were
stained with hematoxylin and eosine for visualization, and
counted.
2.8. Quantitative PCR analysis
Total RNA was extracted using Trizol (Invitrogen), treated with
DNase I (Takara) to eliminate contaminating genomic DNA, and re-
verse-transcribed into cDNA with the Reverse Transcriptase M-
MLV (TaKaRa). Real time PCR was performed using a SYBR Premix
Ex Taq™ kit (TaKaRa) on the iQ5 Real-Time PCR Detection System
(Bio-Rad, Hercules, CA, USA). PCR primers used were as follows:
RhoB FW, 50-cggactcgctggagaaca-30 and RV, 50-gaggtagtcgtaggcttg-
gat-30; b-actin FW, 50-tgacgtggacatccgcaaag-30 and RV, 50-
ctggaaggtggacagcgagg-30. For analysis of miRNA expression by
qRT-PCR, reverse transcription and PCR were carried out using
Bulge-Loop™ miRNA qPCR Primer Set for hsa-miR-21 (RiboBio,
MQP-0101), and U6 snRNA (RiboBio, MQP-0201) according to the
manufacturer’s instructions. Expression of RhoB, relative to b-actin
and miR-21, relative to U6, was determined using the 2DDCT
method.
2.9. Western blot
Total-cell lysates were prepared using RIPA buffer (150 mM
NaCl, 1% NP-40, 50 mM Tris–HCl (pH 7.4), 1 mM phenylmethylsul-
fonyl ﬂuoride, 1 lg/ml leupeptin, 1 mM deoxycholic acid and
1 mM EDTA) containing a cocktail of protease inhibitors and phos-
phatase inhibitors (Calbiochem, Darmstadt, Germany). Equal
amounts of protein sample (60–80 lg) was separated by 12%
SDS–PAGE and transferred to PVDF membrane (Millipore, Bedford,
MA, USA) using the Bio-Rad semidry transfer system. The following
antibodies were used for Western blotting: Anti-RhoB (Becton
Dickinson), Anti-b-actin (Santa Cruz, CA, USA). Blotted proteins
were detected and quantiﬁed using the ODYSSEY Infrared Imaging
System (Li-COR Biosciences, Lincoln, NE, USA).
Fig. 1. 30 UTR of RhoB contains a putative target site for miR-21 that is highly
conserved across species. (A) A schematic representation of the RhoB mRNA
putative sites targeted by miR-21. (B) Comparison of nucleotide sequences of miR-
21 seed sequences with putative target sequence in different species. Sequence
analyses indicate that miR-21 target sequence at nt 2309–2315 of the RhoB 30 UTR
is highly conserved across different species. The target-site for miR-21 within the
RhoB 30 UTR at nt 2309–2315 (AUAAGCU) is underlined.
Fig. 2. miR-21 expression is inversely correlated with RhoB expression. (A)
Western-blot analysis for RhoB in HEK293 and 7 colorectal cancer cell lines. (B)
The intensities of blots in (A) were quantiﬁed with the ODYSSEY Infrared Imaging
System (Li-COR Biosciences). (C) qRT-PCR analysis for miR-21 expression in HEK293
and 7 colorectal cancer cell lines. The miR-21 expression was normalized to U6
expression using the 2DDCT method. RhoB protein expressions are inversely
correlated with miR-21 expressions (P = 0.012). (D) qRT-PCR analysis for RhoB
mRNA expression in HEK293 and 7 colorectal cancer cell lines. The differences in
RhoB protein are higher than for RhoB-mRNA, and RhoB protein and mRNA levels
inversely correlate with miR-21. Data are representative of three independent
experiments performed in triplicate.
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Assays for characterizing phenotypes of cells were analyzed by
Student’s test or One-Way ANOVA and correlations between
groups were calculated with Pearson. P values of <0.05 were
deemed statistically signiﬁcant. Data analysis was achieved using
SPSS for windows version 14.0 (SPSS, Chicago, USA).
3. Results
3.1. miR-21 is a putative regulator targeting RhoB
To identify miRNAs that regulate RhoB expression in colorectal
cancer, we designed a miRNA screening assay using a miRNA target
database of mammalian cells. We performed a bioinformatic
search for putative miRNAs predicted to target RhoB coding or
non-coding sequences using TargetScan and PicTar and found that
the 30 UTR of human RhoB gene harbored multiple putative miRNA
target sites. miRNAs including hsa-miR-19, hsa-miR-30, hsa-let-7d,
hsa-miR-21, hsa-miR-183, hsa-miR-186, hsa-miR-138, hsa-miR-
96, hsa-miR-383, hsa-miR-384, hsa-miR-214, hsa-miR-761,
hsa-miR-410, hsa-miR-590, hsa-miR-494, hsa-miR-411, hsa-miR-
197 and hsa-miR-491 all seem to complement regions of RhoB
gene. Considering the position, number, and sequence conserva-
tion of miRNA target sites across species, combined with the obser-
vation that RhoB protein is down-regulated while miR-21 is
up-regulated in multiple cancer cell lines, we chose miR-21 for fur-
ther characterization. Sequence analysis indicate that miR-21 may
complement nt 2309–2315 sequences of the RhoB 30 UTR that is
highly conserved across different species (Fig. 1).3.2. miR-21 expression is inversely correlated with RhoB protein
expression
Toexamine ifmiR-21may functionally regulateRhoBexpression,
we have examined the expression levels ofmiR-21 and RhoB (mRNA
and protein) in HEK293 and seven different colorectal cancer cell
lines (Fig. 2). In cell lines with low endogenous miR-21 expression,
as measured by quantitative real-time PCR (i.e., HEK293, SW1116
and SW480), relatively high levels of RhoB protein were detected.
Conversely, cell lines with relatively high miR-21 expression
Fig. 3. A putative miR-21 binding site in RhoB 30 UTR is functional in a luciferase
assay. pGL3-RhoB-wt or pGL3-RhoB-mut luciferase constructs containing a wild-
type or a mutated RhoB 30 UTR were cotransfected into HEK293 (A), SW1116 (B)
and SW480 (C) with control miR or miR-21, respectively. Luciferase activity was
determined 36 h after transfection. The ratio of normalized sensor to control
luciferase activity is shown. Data are shown as the mean ± S.D. and were obtained
from three independent experiments performed in triplicate. ⁄Signiﬁcant difference
from control miR-transfected cells (P < 0.05).
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of RhoB protein compared with those containing lower miR-21
expression. Across all eight cell lines tested, we found a signiﬁcant
inverse correlation between miR-21 and RhoB expressions. How-
ever, the differences in RhoBprotein are higher than for RhoB-mRNA
among the cells, and both show an inverse correlation with miR-21
expression (P = 0.012 for RhoB protein, P = 0.038 for RhoB mRNA).
These data suggest that miR-21 expression is inversely correlated
with RhoB expression in human colorectal cancer cells, and it is pos-
sible that miR-21 negatively regulates RhoB post-transcriptionally.
3.3. RhoB is directly regulated by miR-21
To obtain direct evidence that RhoB 30 UTR is a target of miR-21,
the 30 UTR of human RhoB gene was cloned into the Xba1-site of
pGL3-luciferase reporter vector (pGL3-control) (Promega) to test
whether it might serve as a direct functional target of miR-21. This
construct was named pGL3-RhoB-wt. In parallel, another luciferase
reporter construct in which the putative miR-21 targeting region
AUAAGCU, located within nt 2309–2315, was speciﬁcally mutated
and predicted to abolish miR-21 binding, was designated
pGL3-RhoB-mut. Transient transfection of HEK293 (Fig. 3A),
SW1116 (Fig. 3B), and SW480 (Fig. 3C) cells with pGL3-RhoB-wt
and miR-21 led to a signiﬁcant decrease of luciferase activity as
compared to the control. The activity of the mutant reporter con-
struct, however, was unaffected by co-transfection with miR-21.
Next, to examine if miR-21 could affect RhoB expression, we
transfected colorectal cell lines SW1116 and SW480 and HEK293
that show a relatively low miR-21 expression and high RhoB
expression, with miR-21 or control miR, and Colo320 cells that
show a relatively high miR-21 expression and low RhoB expres-
sion, with anti-miR-21 or control-anti-miR. The protein and mRNA
expression levels of RhoB were analyzed by Western blotting and
real-time PCR, respectively. As shown in Fig. 4, compared with
the negative control, transient expression of miR-21 led to a signif-
icant decrease in RhoB protein (Fig. 4A) and mRNA expressions
(Fig. 4B) in HEK293 and colorectal cell lines SW1116 and SW480.
Furthermore, down-regulation of endogenous miR-21 with anti-
miR-21 led to a signiﬁcant increase in RhoB protein expression in
Colo320 cells (Fig. 4C and D). Taken together, these results indicate
that miR-21 directly targets RhoB expression in colorectal cancer
cells.
3.4. miR-21 expression and RhoB knockdown show similar phenotypes
in promoting growth and invasion and suppressing apoptosis of
colorectal cancer cells
Our previous studies show that RhoB play a key role in the reg-
ulation of proliferation of gastric cancer cells [15]. Next we tested
whether miR-21 may regulate growth of coloretal cancer cells and
if this may be through RhoB expression suppression. Fig. 5A shows
the results of CCK-8 assays where ectopic expression of miR-21 or
a RhoB siRNA (si-RhoB) markedly enhanced the proliferation
potential of SW1116 cells. Thus, miR-21 mimicked RhoB expres-
sion knockdown in SW1116 cells, resulting in similar growth phe-
notypes to that by RhoB-speciﬁc siRNA. To understand the
mechanism of the proliferative activity of miR-21, we investigated
the effect of miR-21 on cell apoptosis, because evasion of apoptosis
is a crucial event during malignant transformation. Interestingly,
compared with control oligo transfected cells, ectopic expression
of miR-21 or si-RhoB resulted in a signiﬁcant decrease in apoptosis
rates as determined by Annexin V staining (Fig. 5C). These results
indicate that miR-21 can promote proliferation and inhibit apopto-
sis, effects that are associated with RhoB downregulation.
In addition to proliferation regulation, our previous studies also
show that RhoB is involved in the invasive phenotype of tumorcells that may contribute to the morbidity and mortality of cancer
patients [15]. To determine whether miR-21 may regulate invasion
through RhoB, SW1116 were transfected with miR-21, si-RhoB or
control oligo. In a matrigel invasion assay, we found a signiﬁcant
increase in invasive activity of miR-21-transfected cells, mimicking
that of si-RhoB-transfected cells (Fig. 5B). These data suggest that
miR-21 positively regulates proliferation and invasion of the colo-
rectal cancer cells, and this may, at least in part, be attributed to its
targeting effect on RhoB.
Fig. 4. Ectopic expression of miR-21 or anti-miR-21 regulates both mRNA and protein expression of RhoB. (A) Western-blot analysis of HEK293, SW1116 and SW480 cells
72 h after transfected with miR-21 or control miR for RhoB protein expression. (B) qRT-PCR analysis of RhoB mRNA expression in HEK293, SW1116 and SW480 cells
transfected with miR-21 or control miR. (C) Western-blot analysis of Colo320 cells 72 h after transfected with anti-miR-21 or control anti-miR for RhoB protein expression.
(D) qRT-PCR analysis of RhoB mRNA expression in Colo320 cells transfected with anti-miR-21 or control anti-miR. RhoB mRNA expression was normalized to b-actin mRNA
expression, and data are shown as a ratio of miR-21 or anti-miR-21-transfected cells to control oligo-transfected cells using the 2DDCT method. Data are representative of
three independent experiments performed in triplicate. ⁄Signiﬁcant difference from control oligo-transfected cells (P < 0.05).
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invasion and inducing apoptosis of colorectal cancer cells
To determine whether anti-miR-21 may have a similar effect to
RhoB overexpression on cell proliferation, invasion and apoptosis
in colorectal cancer cells, Colo320 cells with a relatively high
miR-21expressionand lowRhoBexpression,were transiently trans-
fected with anti-miR-21 or a control-anti-miR. Opposite to the
results of miR-21 expression, inhibition of miR-21 by anti-miR-21
markedly suppressed the proliferation and invasion activities of
Colo320 cells (Fig. 6A and B) and enhanced cell apoptosis (Fig. 6C).
Furthermore, RhoB ectopic expression in these cells yielded the
effect mimicking that of anti-miR-21, i.e., signiﬁcantly inhibited
the proliferation and invasion and promotes apoptosis in colorectal
cancer cells. These data further support thatmiR-21-RhoB signaling
axis regulates proliferation and invasion in the colorectal cancer
cells.4. Discussion
Numerous studies in the past few years have shown thatmiRNAs
could serve functionally as ‘‘oncogenes’’ or ‘‘tumor suppressor
genes’’ in tumorigenesis and regulate multiple cellular processes
in the course of cancer progression. miR-21 is one of the most com-
monly implicated miRNAs in cancer. Its expression is highly upreg-
ulated in a variety of solid tumors and elevated miR-21 expression
has been causally linked to proliferation, apoptosis, migration and
drug resistance of several cancer cell lines [23–27,30–32], implying
thatmiR-21 is a key regulatorymolecule in cancer development that
functions by targeting different signaling molecules. However, our
knowledge of the molecular mechanisms mediating miR-21 func-
tion in cancer, particularly in colorectal cancer, is limited. In the
present studies, we have identiﬁed miR-21 as a potential regulator
of RhoB expression in colorectal cancer. A bioinformatics search
revealed a target-site for miR-21 within the RhoB 30 UTR at nt
Fig. 5. miR-21 expression and RhoB knockdown show similar phenotypes in promoting growth and invasion and suppressing apoptosis of colorectal cancer cells. (A)
Proliferation potential of SW1116 transfected with miR-21, si-RhoB or Control oligo was determined by the CCK-8 Assay. The data represent means ± S.D. from three
independent experiments performed in triplicate. (B) The invasive activities of SW1116 transfected with miR-21, si-RhoB or Control oligo were assayed in a matrigel-coated
transwell, and the cells that successfully invaded into the matrigel were quantiﬁed 36 h after plating. Data are representative of three independent experiments. (C) The
apoptosis rates of SW1116 cells 72 h after transfection of miR-21, si-RhoB or Control oligo were determined by FACS analysis. Data are representative of three independent
experiments. ⁄Signiﬁcant difference from control oligo-transfected cells (P < 0.05).
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Expression ofmiR-21 in colorectal cancer cell lineswas found inver-
sely correlated with RhoB expression. miR-21 could signiﬁcantly
suppress RhoB 30 UTR luciferase-reporter activity. Consistent with
the results of a reporter assay, ectopic expression ofmiR-21was able
to reduce bothmRNA and protein expression of RhoB andmimicked
the effect of RhoB-speciﬁc siRNA knockdown in promoting prolifer-
ation and invasion of the colorectal cancer cells. Our results suggest
that miR-21 may have a tumor promoting function by directly tar-
geting the RhoGTPase RhoB in regulating the proliferation and inva-
sion activities of colorectal cancer cells.
To date, biochemical studies have identiﬁed a tightly regulated
GTP-binding/GTP-hydrolysis cycle that is essential for the regula-
tion of Rho family GTPase activities, including RhoB activity. Inter-
estingly, our previous studies show that Rho GTPase activity and
function can be controlled by miRNAs in addition to the classic reg-
ulators such as guanine nucleotide exchange factors and GTPase-
activating proteins. For example, miR-142-3p directly and nega-
tively regulates and suppresses the migration and invasion of
hepatocellular carcinoma cells [33], and our previous studies show
that miR-137 can negatively regulate Cdc42 expression while miR-
185 can directly target both of Cdc42 and RhoA and suppress the
growth and invasion of colorectal cancer cells [22,23]. As a key
member of the Rho GTPase family, RhoB is known to have tumor
suppressor activity, and its down-regulation is associated withmore aggressive tumors as well as changes in cell shape, migration,
and adhesion. In previous studies we have found that RhoA and
RhoC expressions were signiﬁcantly elevated, while RhoB was re-
duced or absent, in surgically removed gastric cancer tissues when
compared to normal gastric tissues. More importantly, RhoB
expression signiﬁcantly inhibited the proliferation, migration and
invasion of the gastric cancer cells and enhanced the chemosensi-
tivity of these cells to anticancer drugs. It appears that RhoB plays
an opposing role from that of RhoA and/or RhoC in gastric cancer
cell regulation [15]. Several studies have explored the mechanism
of decreased RhoB expression in tumor tissues. RhoB gene deletion
or mutation was not found in head and neck carcinomas, and the
level of RhoB mRNA was barely detectable in many cases. Previous
studies showed that RhoB downregulation could be regulated by
histone modiﬁcation. Furthermore, RhoB was reported recently
to be targeted by miR-21 in hepatocellular carcinoma cells and
endothelial cells, and loss of miR-21 causes a reduction in migra-
tion, invasion, and cell elongation [34,35]. Our current work in
colorectal cancer cells are consistent with above studies of hepato-
cellular carcinoma cells, implicating RhoB as an important target
for miR-21 and the miR-21-RhoB signaling axis in mediating cell
proliferation and invasion in colorectal cancer. The results suggest
that RhoB may serve as a useful tool in exploring the potential
therapeutic beneﬁts of targeting of miR-21 mediated tumor cell
behaviors in colorectal cancer.
Fig. 6. Anti-miR-21 mimics RhoB expression in inhibiting cell growth and invasion and inducing apoptosis of colorectal cancer cells. (A) Proliferation potential of Colo320
transfected with anti-miR-21, Control anti-miR, pcEFL-GST or pcEFL-GST-RhoB was determined by the CCK-8 Assay. The data represent means ± S.D. from three independent
experiments performed in triplicate. (B) The invasive activities of Colo320 transfected anti-miR-21, Control anti-miR, pcEFL-GST or pcEFL-GST-RhoB were assayed in a
matrigel-coated transwell, and the cells that successfully invaded into the matrigel were quantiﬁed 36 h after plating. Data are representative of three independent
experiments. (C) The apoptosis rates of Colo320 cells 72 h after transfection of anti-miR-21, control anti-miR, pcEFL-GST or pcEFL-GST-RhoB were determined by FACS
analysis. Data are representative of three independent experiments. ⁄Signiﬁcant difference from control oligo-transfected cells (P < 0.05).
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